Skip to main content
. 2024 May 29;84(5):443–458. doi: 10.1055/a-2286-6066

Fig. 7.

Fig. 7

 Effect of ESR1 mutation on the function of the estrogen receptor (Creative Commons Licence 4.0, 59 ). LBD: ligand-binding domain, AF-2: activating factor-2 domain, DBD: DNA-binding domain, AF-1: activating factor 1 domain, E2: estradiol, SERM: selective estrogen receptor modulator, SERD: selective estrogen receptor degrader, WT: wildtype, MUT: mutated (Source: Brett JO, Spring LM, Bardia A et al. ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer. Breast Cancer Res 2021; 23: 85. doi:10.1186/s13058-021-01462-3.) © 2021. The Author(s). Licensed under a Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/ ). Changes: Addition of explanations for WT and MUT in the image.